Benedict Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.8M | Buy |
47,038
+509
| +1% | +$110K | 2.3% | 11 |
|
|
2026
Q1 | $10.1M | Sell |
46,529
-465
| -1% | -$103K | 2.11% | 12 |
|
|
2025
Q4 | $10.7M | Sell |
46,994
-4
| -0% | -$911 | 2.26% | 10 |
|
|
2025
Q3 | $10.9M | Buy |
46,998
+458
| +1% | +$93.3K | 2.36% | 9 |
|
|
2025
Q2 | $8.64M | Buy |
46,540
+522
| +1% | +$97K | 1.96% | 12 |
|
|
2025
Q1 | $9.64M | Buy |
46,018
+168
| +0.4% | +$32.7K | 2.24% | 10 |
|
|
2024
Q4 | $8.15M | Buy |
45,850
+256
| +0.6% | +$47.1K | 1.98% | 11 |
|
|
2024
Q3 | $9M | Sell |
45,594
-337
| -0.7% | -$62.9K | 2.13% | 8 |
|
|
2024
Q2 | $7.88M | Buy |
45,931
+408
| +0.9% | +$67.6K | 2% | 8 |
|
|
2024
Q1 | $8.29M | Buy |
45,523
+715
| +2% | +$123K | 2.1% | 8 |
|
|
2023
Q4 | $6.94M | Buy |
44,808
+1,119
| +3% | +$163K | 1.89% | 9 |
|
|
2023
Q3 | $6.51M | Buy |
43,689
+1,629
| +4% | +$239K | 1.88% | 8 |
|
|
2023
Q2 | $5.67M | Buy |
42,060
+1,030
| +3% | +$151K | 1.56% | 15 |
|
|
2023
Q1 | $6.54M | Buy |
41,030
+2,487
| +6% | +$380K | 1.84% | 11 |
|
|
2022
Q4 | $6.23M | Buy |
38,543
+1,249
| +3% | +$192K | 1.85% | 11 |
|
|
2022
Q3 | $5M | Buy |
37,294
+1,950
| +6% | +$280K | 1.6% | 14 |
|
|
2022
Q2 | $5.41M | Buy |
35,344
+1,578
| +5% | +$241K | 1.6% | 17 |
|
|
2022
Q1 | $5.47M | Buy |
33,766
+3,948
| +13% | +$573K | 1.46% | 18 |
|
|
2021
Q4 | $4.04M | Buy |
29,818
+7,985
| +37% | +$943K | 1.05% | 34 |
|
|
2021
Q3 | $2.35M | Buy |
21,833
+4,526
| +26% | +$517K | 0.66% | 59 |
|
|
2021
Q2 | $1.95M | Buy |
17,307
+7,938
| +85% | +$894K | 0.54% | 66 |
|
|
2021
Q1 | $1.01M | Buy |
9,369
+1,911
| +26% | +$204K | 0.29% | 91 |
|
|
2020
Q4 | $799K | Buy |
7,458
+570
| +8% | +$54.8K | 0.29% | 81 |
|
|
2020
Q3 | $603K | Buy |
6,888
+4,009
| +139% | +$377K | 0.23% | 84 |
|
|
2020
Q2 | $283K | Buy |
2,879
+54
| +2% | +$4.75K | 0.12% | 92 |
|
|
2020
Q1 | $215K | Buy |
2,825
+71
| +3% | +$6.05K | 0.1% | 93 |
|
|
2019
Q4 | $244K | Buy |
2,754
+10
| +0.4% | +$830 | 0.1% | 99 |
|
|
2019
Q3 | $208K | Sell |
2,744
-302
| -10% | -$20.7K | 0.09% | 102 |
|
|
2019
Q2 | $221K | Buy |
3,046
+302
| +11% | +$23.7K | 0.09% | 103 |
|
|
2019
Q1 | $221K | Buy |
2,744
+326
| +13% | +$26.7K | 0.1% | 102 |
|
|
2018
Q4 | $223K | Buy |
2,418
+9
| +0.4% | +$791 | 0.11% | 97 |
|
|
2018
Q3 | $228K | Buy |
2,409
+8
| +0.3% | +$759 | 0.1% | 103 |
|
|
2018
Q2 | $222K | Buy |
2,401
+7
| +0.3% | +$684 | 0.11% | 99 |
|
|
2018
Q1 | $227K | Buy |
2,394
+5
| +0.2% | +$549 | 0.11% | 99 |
|
|
2017
Q4 | $231K | Sell |
2,389
-296
| -11% | -$27.9K | 0.11% | 103 |
|
|
2017
Q3 | $239K | Buy |
+2,685
| New | +$204K | 0.12% | 101 |
|
Other funds holding ABBV
LMFP
HCM
AAMU
HPC
CRM
CNB
Benedict Financial Advisors's ABBV Position: Q2 2026 in Review
Benedict Financial Advisors increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $110K and bringing the position to 47,038 shares worth $11.8M. The position accounts for 2.3% of the portfolio, ranked #11.
Benedict Financial Advisors first reported a position in ABBV in Q3 2017 and has held it in 36 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Benedict Financial Advisors held 47,038 shares of AbbVie worth $11.8M as of Q2 2026.
- Benedict Financial Advisors bought 509 AbbVie shares in Q2 2026, an estimated $110K.
- AbbVie made up 2.3% of Benedict Financial Advisors's portfolio in Q2 2026, its #11 holding.
- Benedict Financial Advisors first reported a position in AbbVie in Q3 2017 and has held it in 36 quarters since.
- 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Benedict Financial Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.